Sotera Health (SH5) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SH5 Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Sotera

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SH5 Stock 12 Month Forecast

Average Price Target

€18.68

▲(29.75% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is €18.68 with a high forecast of €21.02 and a low forecast of €16.64. The average price target represents a 29.75% change from the last price of €14.40.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"€8","15":"€15","22":"€22","11.5":"€11.5","18.5":"€18.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21.01929576,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€21.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":18.68381845333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€18.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.64027581,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€16.64</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,11.5,15,18.5,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.5,15.924561212307692,16.349122424615384,16.773683636923078,17.19824484923077,17.622806061538462,18.047367273846152,18.471928486153846,18.896489698461536,19.32105091076923,19.74561212307692,20.170173335384614,20.594734547692305,{"y":21.01929576,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.5,15.744909111794872,15.989818223589744,16.234727335384616,16.479636447179487,16.72454555897436,16.96945467076923,17.2143637825641,17.45927289435897,17.704182006153843,17.949091117948715,18.194000229743587,18.43890934153846,{"y":18.68381845333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.5,15.587713523846153,15.675427047692308,15.763140571538461,15.850854095384616,15.938567619230769,16.026281143076922,16.113994666923077,16.20170819076923,16.289421714615383,16.377135238461538,16.464848762307692,16.552562286153844,{"y":16.64027581,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.8,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.55,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€21.02

Average Price Target€18.68

Lowest Price Target€16.64

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Halsted

RBC Capital

€21.02

Buy

45.97%

Upside

Reiterated

07/08/26

RBC Capital Sticks to Its Buy Rating for Sotera Health (SHC)

Luke Sergott

Barclays

€15.76→€16.64

Buy

15.56%

Upside

Assigned

06/24/26

Sotera Health (SHC) Gets a Buy from Barclays

Jason Bednar

Piper Sandler

€19.27

Buy

33.80%

Upside

Reiterated

06/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Evie Koslosky

Goldman Sachs

€17.52

Buy

21.64%

Upside

Initiated

06/05/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Pharma Mar SA (Other OTC: PHMMF) and Sotera Health (NASDAQ: SHC)

Patrick B Donnelly

Citi

€20.14

Buy

39.89%

Upside

Reiterated

05/28/26

Sotera Health (SHC) Receives a Buy from Citi

Sean Dodge

BMO Capital

€17.52

Buy

21.64%

Upside

Reiterated

05/06/26

Sotera Health (SHC) Gets a Buy from BMO Capital

David Windley

Jefferies

€17.08

Buy

18.60%

Upside

Reiterated

11/20/25

Jefferies Keeps Their Buy Rating on Sotera Health (SHC)

Casey Woodring

J.P. Morgan

€12.26→€14.01

Hold

-2.69%

Downside

Reiterated

11/05/25

J.P. Morgan Sticks to Its Hold Rating for Sotera Health (SHC)

Brett Fishbin

KeyBanc

―

Hold

―

Reiterated

11/05/25

Sotera Health (SHC) Receives a Hold from KeyBanc

Michael Polark

Wolfe Research

€14.01→€14.89

Buy

3.39%

Upside

Reiterated

08/08/25

Wolfe Research Sticks to Its Buy Rating for Sotera Health (SHC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Halsted

RBC Capital

€21.02

Buy

45.97%

Upside

Reiterated

07/08/26

RBC Capital Sticks to Its Buy Rating for Sotera Health (SHC)

Luke Sergott

Barclays

€15.76→€16.64

Buy

15.56%

Upside

Assigned

06/24/26

Sotera Health (SHC) Gets a Buy from Barclays

Jason Bednar

Piper Sandler

€19.27

Buy

33.80%

Upside

Reiterated

06/10/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Evie Koslosky

Goldman Sachs

€17.52

Buy

21.64%

Upside

Initiated

06/05/26

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Pharma Mar SA (Other OTC: PHMMF) and Sotera Health (NASDAQ: SHC)

Patrick B Donnelly

Citi

€20.14

Buy

39.89%

Upside

Reiterated

05/28/26

Sotera Health (SHC) Receives a Buy from Citi

Sean Dodge

BMO Capital

€17.52

Buy

21.64%

Upside

Reiterated

05/06/26

Sotera Health (SHC) Gets a Buy from BMO Capital

David Windley

Jefferies

€17.08

Buy

18.60%

Upside

Reiterated

11/20/25

Jefferies Keeps Their Buy Rating on Sotera Health (SHC)

Casey Woodring

J.P. Morgan

€12.26→€14.01

Hold

-2.69%

Downside

Reiterated

11/05/25

J.P. Morgan Sticks to Its Hold Rating for Sotera Health (SHC)

Brett Fishbin

KeyBanc

―

Hold

―

Reiterated

11/05/25

Sotera Health (SHC) Receives a Hold from KeyBanc

Michael Polark

Wolfe Research

€14.01→€14.89

Buy

3.39%

Upside

Reiterated

08/08/25

Wolfe Research Sticks to Its Buy Rating for Sotera Health (SHC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BBOTBridgeBio Oncology Therapeutics

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sotera Health

3 Months

David WindleyJefferies

Success Rate

7/12 ratings generated profit

Average Return

+3.96%

Copying David Windley's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +3.96% per trade.

1 Year

David WindleyJefferies

Success Rate

6/12 ratings generated profit

Average Return

+3.21%

Copying David Windley's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.21% per trade.

2 Years

David WindleyJefferies

Success Rate

9/12 ratings generated profit

Average Return

+15.69%

Copying David Windley's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +15.69% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SH5 Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SH5 has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SH5 average Analyst price target in the past 3 months is 18.68.

Each month's total comprises the sum of three months' worth of ratings.

SH5 Financial Forecast

SH5 Earnings Forecast

Next quarter’s earnings estimate for SH5 is €0.21 with a range of €0.20 to €0.22. The previous quarter’s EPS was €0.16. SH5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.

SH5 Sales Forecast

Next quarter’s sales forecast for SH5 is €271.19M with a range of €269.22M to €273.23M. The previous quarter’s sales results were €245.26M. SH5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.

SH5 Stock Forecast FAQ

What is DE:SH5’s average 12-month price target, according to analysts?

Based on analyst ratings, Sotera Health Company’s 12-month average price target is 18.68.

What is DE:SH5’s upside potential, based on the analysts’ average price target?

Sotera Health Company has 29.75% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Sotera Health Company a Buy, Sell or Hold?

Sotera Health Company has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is Sotera Health Company’s share price target?

The average share price target for Sotera Health Company is 18.68. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €21.02 ,and the lowest forecast is €16.64. The average share price target represents 29.75% Increase from the current price of €14.4.

What do analysts say about Sotera Health Company?

Sotera Health Company’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of Sotera Health Company?

To buy shares of DE:SH5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Sotera Health (SH5) Stock Forecast & Price Target

SH5 Analyst Ratings

SH5 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sotera Health

SH5 Analyst Recommendation Trends

SH5 Financial Forecast

SH5 Earnings Forecast

SH5 Sales Forecast

SH5 Stock Forecast FAQ

Detailed List of Analyst Forecasts